Amneal Pharmaceuticals In... (AMRX)
NASDAQ: AMRX
· Real-Time Price · USD
9.43
0.04 (0.43%)
At close: Aug 15, 2025, 12:25 PM
Amneal Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 2.85B | 2.83B | 2.79B | 2.68B | 2.6B | 2.5B | 2.39B | 2.39B | 2.31B | 2.27B | 2.21B | 2.14B | 2.12B | 2.1B | 2.09B | 2.07B | 2.06B | 1.99B |
Cost of Revenue | 1.78B | 1.79B | 1.77B | 1.69B | 1.64B | 1.57B | 1.53B | 1.54B | 1.5B | 1.48B | 1.43B | 1.4B | 1.38B | 1.35B | 1.32B | 1.3B | 1.35B | 1.35B |
Gross Profit | 1.07B | 1.04B | 1.02B | 994.05M | 957.02M | 927.09M | 867.22M | 846.13M | 807.83M | 788.32M | 784.71M | 735.72M | 740M | 751.98M | 768.97M | 769.64M | 704.72M | 636.46M |
Operating Income | 376.32M | 360.42M | 249.33M | 187.73M | 174.56M | 159.18M | 204.37M | 264.38M | 233.08M | -45.62M | -56.76M | -119.78M | -135.62M | 130.11M | 152.72M | 161.72M | 135.64M | 79.27M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | 49.31M | 96.34M | 138.73M | 138.73M | 89.42M | 42.39M | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 89.3M | 57.99M | -55.01M | -123.16M | -115.62M | -106.37M | -40.27M | 35.54M | 14.76M | -247.63M | -248.13M | -256.79M | -261.01M | 6.54M | 31.37M | 42.21M | 22.36M | -34.22M |
Net Income | 3.38M | -13.05M | -116.89M | -184.45M | -174.62M | -168.69M | -87.14M | 5.65M | -6.42M | -139.15M | -135.52M | -136.03M | -137.88M | -2.54M | 10.62M | 13.96M | 9.23M | -17.3M |
Selling & General & Admin | 489.93M | 482.13M | 476.44M | 456.75M | 451.07M | 440.17M | 429.68M | 422.83M | 409.89M | 403.13M | 399.7M | 394.77M | 386.09M | 373.44M | 365.5M | 352.97M | 344.69M | 339.48M |
Research & Development | 206.99M | 196.12M | 193.61M | 184.06M | 165.22M | 166.74M | 167.78M | 164.48M | 173.87M | 186.82M | 200.05M | 209.79M | 208.7M | 211.36M | 209.56M | 213.71M | 209.81M | 204.7M |
Other Expenses | 702K | -396K | 4.16M | 2.29M | 2.95M | -2.23M | -3.45M | -5.33M | -8.26M | -4.01M | -2.79M | -1.32M | n/a | n/a | 794K | 1.28M | 2.18M | 2.75M |
Operating Expenses | 697.62M | 677.85M | 674.2M | 642.69M | 618.82M | 604.28M | 593.59M | 581.99M | 575.5M | 584.76M | 595.79M | 602.06M | 593.62M | 584.8M | 575.07M | 566.67M | 554.5M | 544.18M |
Interest Expense | 249.21M | 249.83M | 258.6M | 256.48M | 241.88M | 227.02M | 210.63M | 198.11M | 189.59M | 174.36M | 158.38M | 145.31M | 137.31M | 135.78M | 136.32M | 136.9M | 137.4M | 139.98M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 2.47B | 2.47B | 2.45B | 2.4B | 2.33B | 2.24B | 2.19B | 2.12B | 2.08B | 2.07B | 2.02B | 2.01B | 1.98B | 1.93B | 1.9B | 1.86B | 1.91B | 1.89B |
Income Tax Expense | 38.06M | 25.57M | 18.86M | 23.32M | 17.58M | 13.94M | 8.45M | -3.23M | 3.42M | 10.79M | 6.66M | 12.6M | 12.08M | 7.38M | 11.2M | 8.54M | 4.64M | 4.17M |
Shares Outstanding (Basic) | 313.74M | 311.05M | 309.85M | 309.65M | 309.12M | 305.48M | 243.71M | 161.37M | 153.74M | 152.11M | 151.48M | 151.39M | 150.99M | 149.89M | 149.37M | 149.29M | 149M | 148.01M |
Shares Outstanding (Diluted) | 322.36M | 323.96M | 309.85M | 309.65M | 318.96M | 307.28M | 243.71M | 159.69M | 154.89M | 152.11M | 151.48M | 151.39M | 150.99M | 149.89M | 149.37M | 149.29M | 151.99M | 151.22M |
EPS (Basic) | 0.01 | -0.04 | -0.38 | -0.68 | -0.62 | -0.56 | -0.33 | 0.03 | -0.04 | -0.92 | -0.9 | -0.9 | -0.91 | -0.01 | 0.08 | 0.10 | 0.07 | -0.11 |
EPS (Diluted) | 0.01 | -0.04 | -0.38 | -0.68 | -0.62 | -0.56 | -0.33 | 0.03 | -0.04 | -0.92 | -0.9 | -0.9 | -0.91 | -0.01 | 0.07 | 0.09 | 0.06 | -0.12 |
EBITDA | 583.88M | 558.91M | 545.04M | 570.89M | 562.07M | 547.74M | 513.15M | 512.64M | 487.71M | 212.67M | 186.69M | 148.24M | 159.53M | 425.54M | 450M | 435.75M | 413.85M | 358.25M |
EBIT | 338.51M | 307.83M | 203.58M | 238.63M | 231.56M | 225.96M | 275.66M | 233.65M | 204.35M | -73.28M | -89.75M | -111.48M | -123.7M | 142.32M | 167.69M | 179.11M | 159.76M | 105.76M |
Depreciation & Amortization | 245.36M | 240.82M | 236.19M | 226.99M | 225.24M | 226.78M | 229.4M | 233.52M | 237.93M | 240.51M | 240.18M | 240.3M | 238.88M | 235.67M | 233.41M | 232.1M | 231.27M | 232.85M |